Opexa Therapeutics (OPXA) Supports National Multiple Sclerosis Society as a Corporate Sponsor of Walk MS  
10/23/2013 10:14:44 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS) announced it will be a key sponsor of the National Multiple Sclerosis Society’s Walk MS series of events being held in the Houston area and Austin, Texas, during October and November.

Help employers find you! Check out all the jobs and post your resume.